Terminated NA INTERVENTIONAL 2-arm NCT00566111

Ceftriaxone in the Management of Bipolar Depression

Modulation of Glutamatergic Neurotransmission in the Treatment of Bipolar Depression

Sponsor: Stanley Medical Research Institute

Interventions Saline solution ceftriaxone

Updated 7 times since 2017 Last updated: Mar 27, 2020 Started: Sep 30, 2007 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Early indication of an unfavorable risk/benefit ratio.

Other Bipolar Depression trials with similar outcome

Browse all Bipolar Depression trials

Listed as NCT00566111, this NA trial focuses on Bipolar Depression and remains terminated or withdrawn. Sponsored by Stanley Medical Research Institute, it has been updated 7 times since 2007, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Apr 2020 — Jan 2021 [monthly]

Terminated NA
Jun 2018 — Apr 2020 [monthly]

Terminated NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanley Medical Research Institute
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States